Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 533 (LINC00533) is a human non-coding RNA gene located on chromosome 6[3]. It belongs to the family of long intergenic non-coding RNAs (lincRNAs), a class of RNAs longer than 200 nucleotides that do not overlap with protein-coding genes and are generally thought to act as regulators of gene expression or chromatin state[1][3][5]. The function, tissue specificity, and disease relevance of LINC00533 are not described in major functional genomics databases, and there is currently no evidence supporting a direct role for LINC00533 as a therapeutic target, disease biomarker, or molecular mechanism in drug action[1][3]. More broadly, some lincRNAs have been implicated in the control of gene expression, chromatin remodeling, and disease, but such roles are typically highly specific and must be established for each transcript individually; this is not the case for LINC00533 as of the latest data[1][3][5].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 533 (LINC00533).